Biotechnology
News Category
VERAXA Biotech Receives Positive Regulatory Feedback from Germany for BiTAC-TCE Development
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead BiTAC-TCE program...
Onco-Innovations Advances Precision Oncology with ONC010 as Biomarker-Driven Cancer Gains Momentum
Onco-Innovations is progressing its lead nanoparticle-encapsulated PNKP inhibitor ONC010 for biomarker-selected cancers, aligning with the industry sh...
Lantern Pharma Receives U.S. Patent Allowance for Biomarker-Based Cancer Treatment Methods
The U.S. Patent and Trademark Office has allowed a patent for Lantern Pharma's LP-184 therapy selection method using a three-gene biomarker signature,...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance Cancer Therapies
VERAXA Biotech appoints Christoph Erkel as CSO to lead development of its BiTAC platform for solid tumor cancer therapies, leveraging his two decades ...
iOrganBio Appoints Lee L. Rubin, Ph.D. to Scientific Advisory Board to Advance Neurological Applications
iOrganBio expands its Scientific Advisory Board with the appointment of Harvard stem cell expert Dr. Lee L. Rubin, aiming to leverage his expertise to...
BioAdaptives Completes Manufacturing Readiness, Set to Launch Wellness Platforms Next Month
BioAdaptives has finalized commercial manufacturing and logistics for its MyndSystem and Xcellara wellness platforms, targeting the cognitive and cell...
Creative Biolabs Expands Microfluidics Portfolio to Accelerate High-Throughput Antibody Discovery
The expansion integrates droplet generation systems, customizable chips, and immune checkpoint services to improve screening throughput and data repro...
Quantum BioPharma Targets Multiple Sclerosis and Alcohol Intoxication with Novel Pipeline
Quantum BioPharma is advancing a two-pronged approach to neurological disorders, with Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxica...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Deciparticle Formulation of Everolimus
Oncotelic Therapeutics announced the publication of preclinical data in Biomedicines supporting Sapu003, its intravenous Deciparticle formulation of e...
Kairos Pharma Partners with Bayer to Evaluate Combination Therapy for Advanced Prostate Cancer
Kairos Pharma has entered a collaboration with Bayer to test its antibody ENV-105 in combination with Xofigo for metastatic castration-resistant prost...
VERAXA Biotech Receives Positive Regulatory Feedback from German PEI for BiTAC(R)-TCE Program
VERAXA Biotech AG obtained Scientific Advice from Germany's Paul-Ehrlich-Institute, supporting its development strategy for the lead BiTAC(R)-TCE cand...
VivoSim Labs Raises $4 Million in Private Placement with Healthcare-Focused Investor
VivoSim Labs secures $4 million from a healthcare-focused investor to fund working capital and general corporate purposes, highlighting continued inte...
Greenwich LifeSciences Advances Phase 3 Trial for Breast Cancer Immunotherapy GLSI-100
Greenwich LifeSciences announced continued progress in its Phase 3 FLAMINGO-01 trial for GLSI-100, including DSB approval and expanded enrollment, whi...
Quantum BioPharma Targets Unmet Needs in Multiple Sclerosis and Alcohol Intoxication
Quantum BioPharma Ltd. is advancing two novel therapies: Lucid-MS for multiple sclerosis and unbuzzd for alcohol-induced cognitive impairment, address...
American Fusion Inc. Secures Texas Certificate of Registration for Fusion Engine Testing
American Fusion Inc. received a Texas DSHS Certificate of Registration for Industrial Radiation Machines, enabling testing of its Texatron Fusion Engi...
WHO-Led Study Finds No Evidence Mobile Phones Cause Brain Cancer
A comprehensive review commissioned by the World Health Organization found no link between mobile phone use and brain cancer, addressing long-standing...
Quantum BioPharma Hits Key MS Imaging Study Milestone with Promising Early Data
Quantum BioPharma announces halfway enrollment in its PET imaging study for multiple sclerosis, with early data showing a meaningful signal that could...
GeoVax’s GEO-MVA Platform Aligns with ASPR’s $66.9 Billion Five-Year Preparedness Strategy
GeoVax Labs highlights how its GEO-MVA vaccine platform aligns with the U.S. Department of Health and Human Services’ new five-year medical countermea...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech announced positive regulatory feedback from Germany's Paul-Ehrlich-Institute on its BiTAC-TCE platform, advancing its dual-targeting ca...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech AG has received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, providing clarity on development st...
Regentis Biomaterials Secures Japan Patent for GelrinC Manufacturing Technology, Bolstering IP Portfolio
Regentis Biomaterials received a Japan patent allowance for its organic solvent-free manufacturing process for GelrinC, strengthening its intellectual...
MindBio Therapeutics Advances Voice-Based AI for Real-Time Impairment Detection
MindBio Therapeutics is developing an AI-powered voice analysis platform that detects drug and alcohol impairment from short speech samples, offering ...
Gut Metabolites Linked to Improved Cancer Immunotherapy Response
A recent study found that metabolites from gut bacteria are associated with better responses to cancer immunotherapy, offering a potential biomarker f...
SS Innovations Appoints Veteran Medtech CFO as Global Robotic Surgery Expansion Accelerates
SS Innovations International has appointed Sarah M. Romano as CFO to bolster financial leadership amid global expansion of its SSi Mantra surgical rob...
Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Advance POCT Diagnostics
Creative Biolabs has launched a new platform combining microfluidics and electrochemical biosensors to accelerate the development of point-of-care tes...
BioAdaptives Details Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives outlines its Xcellara cellular wellness platform strategy, which combines a clinically proven stem cell mobilization base with tissue-spe...
NeuroOne Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic, funded by a Children's Cancer Research Fund grant, to evaluate a novel treat...
Oncotelic Therapeutics Launches AI-Powered Manufacturing Platform to Address GMP Infrastructure Gap for Biotechs
Oncotelic Therapeutics introduced an AI and robotics-driven manufacturing platform aimed at helping emerging biotech companies overcome the challenge ...
Quantum BioPharma Advances Neuroprotective Therapy for Multiple Sclerosis
Quantum BioPharma's LUCID-MS, a potential first-in-class therapy directly targeting myelin loss and neurodegeneration, advances to Phase 2 trials afte...
VERAXA Biotech’s AI Collaboration May Unlock Safer, More Effective Cancer Therapies
VERAXA Biotech's partnership with AI firm Ardigen aims to leverage artificial intelligence for target discovery and validation, potentially reducing d...
Tonix Pharmaceuticals Publishes Mpox Research Supporting TNX-801 Vaccine Development
Tonix Pharmaceuticals published new research in the Journal of Virology showing significant differences in virulence between mpox virus clade IIb and ...
Nuvectis Pharma Prices $100 Million Public Offering to Advance Pipeline Programs
Nuvectis Pharma announced the pricing of a $100 million public offering to fund development of its NXP100, NXP200, and NXP900 programs, highlighting i...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced promising interim safety results from its Phase 1 trial of ENV-105 combined with osimertinib in advanced EGFR-mutated NSCLC pa...
NeuroThera Labs Starts Phase IIb Trial of SCI-110 for Tourette Syndrome at Hannover Medical School
NeuroThera Labs has initiated a Phase IIb clinical trial for its cannabinoid-based treatment SCI-110 at Hannover Medical School, aiming to address unm...
Earth Science Tech Inc. Leverages Technology and Strategic Positioning to Advance Telehealth and Peptide Therapy Markets
Earth Science Tech Inc. (ETST) is capitalizing on the surging telehealth and peptide therapy markets through proprietary technology and vertical integ...
Formycon and OneSource Specialty Pharma Forge Strategic Biosimilar Manufacturing Partnership
Formycon AG and OneSource Specialty Pharma announced a strategic partnership to leverage OneSource's biologics manufacturing capabilities for Formycon...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma reported a favorable safety profile for its proprietary MS therapy LUCID-MS in Phase 1 studies and submitted an IND to the FDA, supp...
Quantum BioPharma Advances LUCID-MS Toward Phase 2 Trials for Multiple Sclerosis
Quantum BioPharma reported positive Phase 1 safety data for its neuroprotective therapy LUCID-MS and submitted an IND to the FDA, positioning it as a ...
Silo Pharma's QwikAgents Subsidiary Joins AMD AI Developer Program to Accelerate AI Platform Development
Silo Pharma's subsidiary QwikAgents has been accepted into AMD's AI Developer Program, gaining access to development tools and cloud credits to enhanc...
VERAXA Biotech Partners with Ardigen to Leverage AI for Cancer Therapy Development
VERAXA Biotech AG has partnered with AI-focused CRO Ardigen to enhance its BiTAC(R) cancer therapy platform through AI-driven target discovery, potent...
DN Group AG's Algene Begins Series Production of Microalgae with First Harvest Yield of 4,500 Litres
Algene Holding SE, a subsidiary of DN Group AG, has successfully completed its first harvest of high-purity microalgae, achieving a yield of 4,500 lit...
VERAXA Biotech Partners With Ardigen to Advance AI-Driven Cancer Drug Development
VERAXA Biotech (NASDAQ: VRXA) has partnered with Ardigen S.A. to integrate artificial intelligence into its BiTAC pipeline, aiming to improve target s...
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides received National Ethics Committee approval in the DRC for a Phase II trial of NV-387 oral gummies against Bundibugyo ebolavirus, positi...
Tonix Pharmaceuticals Expands Medicare Coverage for TONMYA, Reaching 145 Million Covered Lives
Tonix Pharmaceuticals announced a major managed Medicare agreement for TONMYA, expanding pharmacy coverage to approximately 145 million lives, or 46% ...
VERAXA Biotech Partners with Ardigen to Apply AI in Cancer Drug Development
VERAXA Biotech AG has partnered with Ardigen to use artificial intelligence to enhance its BiTAC pipeline of T-cell engagers, aiming to improve target...
Onco-Innovations Completes Analytical Reference Standard Program for ONC010, Advancing Toward Clinical Readiness
Onco-Innovations Limited has completed an analytical reference standard program for its lead oncology candidate ONC010, strengthening its CMC framewor...
VERAXA Biotech Appoints Carl von Halem as Interim CFO Amid Leadership Transition
VERAXA Biotech names Carl von Halem interim CFO as it finalizes a permanent candidate to support expansion, leveraging his experience in corporate fin...
Novel feeder-free TIL expansion platform reduces IL-2 dependence, improves safety and efficacy in preclinical study
Researchers developed a feeder-free tumor-infiltrating lymphocyte (TIL) expansion protocol using low-dose IL-2, which combined with low-dose PD-1 bloc...